BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18446840)

  • 1. Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered (-)epigallocatechin-3-gallate from green tea extract: a human study.
    Gawande S; Kale A; Kotwal S
    Phytother Res; 2008 Jun; 22(6):802-8. PubMed ID: 18446840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract.
    Kale A; Gawande S; Kotwal S; Netke S; Roomi W; Ivanov V; Niedzwiecki A; Rath M
    Phytother Res; 2010 Jan; 24 Suppl 1():S48-55. PubMed ID: 19585479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral absorption and bioavailability of tea catechins.
    Zhu M; Chen Y; Li RC
    Planta Med; 2000 Jun; 66(5):444-7. PubMed ID: 10909265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CYP1A by green tea extract in human intestinal cell lines.
    Netsch MI; Gutmann H; Schmidlin CB; Aydogan C; Drewe J
    Planta Med; 2006 May; 72(6):514-20. PubMed ID: 16773535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and pharmacokinetics of green tea catechins in beagles.
    Mata-Bilbao Mde L; Andrés-Lacueva C; Roura E; Jáuregui O; Escribano E; Torre C; Lamuela-Raventós RM
    Br J Nutr; 2008 Sep; 100(3):496-502. PubMed ID: 18205995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
    Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
    Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
    Lambert JD; Kim DH; Zheng R; Yang CS
    J Pharm Pharmacol; 2006 May; 58(5):599-604. PubMed ID: 16640828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans.
    Kimura M; Umegaki K; Kasuya Y; Sugisawa A; Higuchi M
    Eur J Clin Nutr; 2002 Dec; 56(12):1186-93. PubMed ID: 12494303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin penetration of epigallocatechin-3-gallate and quercetin from green tea and Ginkgo biloba extracts vehiculated in cosmetic formulations.
    dal Belo SE; Gaspar LR; Maia Campos PM; Marty JP
    Skin Pharmacol Physiol; 2009; 22(6):299-304. PubMed ID: 19786823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate.
    Dube A; Nicolazzo JA; Larson I
    Eur J Pharm Sci; 2010 Oct; 41(2):219-25. PubMed ID: 20600878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
    Pandit AP; Joshi SR; Dalal PS; Patole VC
    BMC Complement Altern Med; 2019 Jun; 19(1):129. PubMed ID: 31196040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro transdermal delivery of the major catechins and caffeine from extract of Camellia sinensis.
    Batchelder RJ; Calder RJ; Thomas CP; Heard CM
    Int J Pharm; 2004 Sep; 283(1-2):45-51. PubMed ID: 15363500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited sampling estimates of epigallocatechin gallate exposures in cirrhotic and noncirrhotic patients with hepatitis C after single oral doses of green tea extract.
    Halegoua-De Marzio D; Kraft WK; Daskalakis C; Ying X; Hawke RL; Navarro VJ
    Clin Ther; 2012 Dec; 34(12):2279-2285.e1. PubMed ID: 23153661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of green tea and (-)-epigallocatechin gallate on ethanol-induced toxicity in HepG2 cells.
    Lee SI; Kim HJ; Boo YC
    Phytother Res; 2008 May; 22(5):669-74. PubMed ID: 18350509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-atherogenic effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine, and green tea phenolics in human aortic smooth muscle cells.
    Ivanov V; Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):140-5. PubMed ID: 17414225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
    Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extract of green tea, epigallocatechin-3-gallate, reduces periapical lesions by inhibiting cysteine-rich 61 expression in osteoblasts.
    Lee YL; Hong CY; Kok SH; Hou KL; Lin YT; Chen MH; Wang CC; Lin SK
    J Endod; 2009 Feb; 35(2):206-11. PubMed ID: 19166774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal efflux transport kinetics of green tea catechins in Caco-2 monolayer model.
    Chan KY; Zhang L; Zuo Z
    J Pharm Pharmacol; 2007 Mar; 59(3):395-400. PubMed ID: 17331343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies.
    Isbrucker RA; Edwards JA; Wolz E; Davidovich A; Bausch J
    Food Chem Toxicol; 2006 May; 44(5):636-50. PubMed ID: 16387402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.